Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?
about
Adverse Effects of GLP-1 Receptor AgonistsPitavastatin and carbohydrate metabolism: what is the evidence?Dapagliflozin in patients with type 2 diabetes mellitus.Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population.Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy.The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].Safety considerations with fenofibrate/simvastatin combination.Acid-base and electrolyte disorders associated with the use of antidiabetic drugs.Effects of sodium-glucose co-transporter 2 inhibitors on metabolism: unanswered questions and controversies.Paraoxonase 1 Activity, Lipid Profile, and Atherogenic Indexes Status in Coronary Heart Disease.SGLT2 inhibitors: are they safe?New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies.
P2860
Q26801346-8A337170-4DC0-479F-91EB-41AD407D016FQ30251801-D82496FB-4436-469E-BD63-73E13FC4ED44Q35064363-7BE62C17-B746-41F2-8667-E0E931A23569Q36550320-8038E9B8-46E2-4DA4-838A-331E7BECD2B0Q37653029-9FA3B2CD-3275-48F1-B40A-AAB108FFFDBFQ38205588-77754B1F-7F6C-4518-A08D-1A496F3FB4B6Q38541832-F0BE01C7-663B-4CF0-BCFC-D7BF0BEBAC11Q38658251-6BC19E01-3771-410F-8246-A0D38FF8E691Q39000587-CF496F81-4DCF-4A2B-B2FB-1F6FD45A6C39Q42694446-A2ACC455-7244-40E7-AECA-43DF5B01BA03Q47642298-B1ADA551-1CF8-4004-8727-431166587178Q53401128-6CB6ECCF-C740-4DEE-B824-B790DCA95668
P2860
Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Does combination therapy with ...... therogenic mixed dyslipidemia?
@ast
Does combination therapy with ...... therogenic mixed dyslipidemia?
@en
type
label
Does combination therapy with ...... therogenic mixed dyslipidemia?
@ast
Does combination therapy with ...... therogenic mixed dyslipidemia?
@en
prefLabel
Does combination therapy with ...... therogenic mixed dyslipidemia?
@ast
Does combination therapy with ...... therogenic mixed dyslipidemia?
@en
P2860
P50
P356
P1476
Does combination therapy with ...... therogenic mixed dyslipidemia?
@en
P2093
Aris P Agouridis
P2860
P304
P356
10.1900/RDS.2013.10.171
P577
2013-06-01T00:00:00Z